Journal of Immigrant and Minority Health

, Volume 13, Issue 4, pp 681–689 | Cite as

Substance Use and HIV Risk in a Sample of Severely Mentally Ill Puerto Rican Women

Original Paper


Latinos, and Puerto Ricans in particular, have been disproportionately impacted by HIV/AIDS. Severe mental illness (SMI) is associated with an increase in HIV risk. Relatively little research has focused on the role of SMI among Puerto Rican injection drug users (IDUs) and non-IDUs in susceptibility to and transmission of HIV and there are few published reports on HIV risk among Latina SMI. We conducted a longitudinal mixed methods study with 53 Puerto Rican women with schizophrenia, bipolar disorder, or major depression to examine the cultural context of HIV risk and HIV knowledge, beliefs, and behaviors among a larger study with Puerto Rican and Mexican women with serious mental illness (SMI). There was a high prevalence of past and current substance use and a high prevalence of substance use-associated HIV risk behaviors, such as unprotected sexual relations with an IDU. The violence associated with substance use frequently increased participants’ HIV risk. Choice of substance of abuse depended on cost, availability, and use within the individual participant’s network. Participants attributed their substance use to the need to relieve symptoms associated with their mental illness, ameliorate unpleasant feelings, and deaden emotional pain. HIV prevention interventions for poorer Puerto Rican women with SMI must target the individuals themselves and others within their networks if the women are to be supported in their efforts to reduce substance use-related risk. The content of any intervention must address past and current trauma and its relationship to substance use and HIV risk, as well as strategies to prevent HIV transmission.


Latinas HIV Severe mental illness Substance use 



This study was funded by the National Institute of Mental Health R01 MH63016.

Conflict of interests

None for any author.


  1. 1.
    United States Census Bureau. We the people: hispanics in the United States census 2000 special reports; December 2004. From URL: (2010). Retrieved 16 Aug 2010.
  2. 2.
    Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2005, v.17. rev. ed. Atlanta: United States Department of Health and Human Services, CDC: 2007; 1–46. From: URL: (2010). Retrieved 16 Aug 2010.
  3. 3.
    De La Rosa MR, Holleran LK, Rugh D et al. Substance abuse among U.S. Latinos: A review of the literature. J Soc Work Prac Add 2005; 5(1/2):1–20.Google Scholar
  4. 4.
    Canino G, Anthony JC, Freeman DH Jr, Shrout P, Rubio-Stipec M. Drug abuse and illicit drug use in Puerto Rico. J Pub Health. 1993;83:194–200.CrossRefGoogle Scholar
  5. 5.
    Ortiz A, Medina-Mora ME. Research on drug abuse in Mexico. In: Epidemiology of drug abuse and issues among Native American populations. Community epidemiology work group proceedings, December 1987. Washington, DC. United States Government Printing Office; 1988.Google Scholar
  6. 6.
    Velez N, Ungermack J. Drug use among Puerto Rican youth: an exploration of generational status differences. Soc Sci Med. 1989;29:779–89.PubMedCrossRefGoogle Scholar
  7. 7.
    Colón HM, Robles RR, Sahai H. The validity of drug use responses in a household survey in Puerto Rico: Comparison of survey responses of cocaine and heroin use with hair tests. Int J Epidem. 2001;30:1042–9.CrossRefGoogle Scholar
  8. 8.
    Puerto Rico Department of Health, Epidemiology Division. AIDS surveillance report. Puerto Rico: Author; 2003.Google Scholar
  9. 9.
    Centers for Disease Control and Prevention. HIV/AIDS surveillance report, 2007 vol 19, Table 4. Atlanta: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; 2009. From URL: (2010). Retrieved 16 Aug 2010.
  10. 10.
    Sufian M, Friedman SR, Neaigus A, Stepherson B, Rivera-Bekman J, de Jarlais D. Impact of AIDS on Puerto Rican intravenous drug users. Hisp J Behav Sci. 1990;12(2):122–34.CrossRefGoogle Scholar
  11. 11.
    Kang S-Y, Deren S, Andia J, Colón HM, Robles R. Gender differences in HIV risk behaviors among Puerto Rican drug injectors by awareness of HIV seropositive status. AIDS Behav. 2001;5(3):241–9.CrossRefGoogle Scholar
  12. 12.
    Colón HM, Finlinson HA, Robles RR, Deren S, Andia JF, Kang S-Y, et al. Joint drug purchases and drug preparation risk behaviors among Puerto Rican drug injectors. AIDS Behav. 2001;5(1):85–96.CrossRefGoogle Scholar
  13. 13.
    Deren S, Oliver-Velez D, Finlinson A, Robles R, Andia J, Colón HM et al. Integrating qualitative and quantitative methods: comparing HIV-related risk behaviors among Puerto Rican drug users in Puerto Rico and New York. Sub Use Misuse. 2003: 38:1–24.Google Scholar
  14. 14.
    Finlinson HA, Colón HM, Robles RR, Deren S, Soto Lopez M, Muñoz A. Access to sterile syringes by injection drug users in Puerto Rico. Human Org. 1999;58:201–11.Google Scholar
  15. 15.
    Deren S, Kang S-Y, Colón HM, Andia JF, Robles RR, Oliver-Velez D, et al. Migration and HIV risk behaviors: Puerto Rican drug injectors in New York City and Puerto Rico. AJPH. 2003;93(5):812–6.CrossRefGoogle Scholar
  16. 16.
    Finlinson HA, Oliver-Vélez D, Colón HM, Deren S, Robles RR, Beardsley M, et al. Syringe acquisition and use of syringe exchange programs by Puerto Rican drug injectors in New York and Puerto Rico: comparisons based on quantitative and qualitative methods. AIDS Behav. 2000;4(4):341–51.CrossRefGoogle Scholar
  17. 17.
    Deren S, Robles R, Andia J, Colón HM, Kang S-Y, Perlis J. Trends in HIV seroprevalence and needle sharing among Puerto Rican drug injectors in Puerto Rico and New York: 1992–1999. J AIDS. 2001;26:164–9.Google Scholar
  18. 18.
    Kang S-Y, Deren S, Andia J, Colón HM, Robles R, Oliver-Velez D. HIV transmission behaviors in jail/prison among Puerto Rican drug injectors in New York and Puerto Rico. AIDS Behav. 2005;9(3):377–85.PubMedCrossRefGoogle Scholar
  19. 19.
    Colón HM, Robles RR, Deren S, Sahar H, Finlinson HA, Andia J, et al. Between-city variation in frequency of injection among Puerto Rican injection drug users: East Harlem, New York, and Bayamon, Puerto Rico. J AIDS. 2001;27:405–13.Google Scholar
  20. 20.
    Cournos F, Empfield M, Horwath E, McKinnon K, Meyer I, Schrage H, et al. HIV seroprevalence among patients admitted to two psychiatric hospitals. Am J Psychiatry. 1991;148:1225–30.PubMedGoogle Scholar
  21. 21.
    Cournos F, Horwath E, Guido JR, McKinnon K, Hopkins N. HIV-1 infection at two public psychiatric hospitals in New York City. AIDS Care. 1994;6:443–52.PubMedCrossRefGoogle Scholar
  22. 22.
    Meyer I, Cournos F, Empfield M, Schrage H, Silver M, Rubin M, et al. HIV seroprevalence and clinical characteristics of the mentally ill homeless. J Soc Dist Homeless. 1993;2:103–16.CrossRefGoogle Scholar
  23. 23.
    Meyer I, McKinnon K, Cournos F, Empfield M, Bavli S, Engel D, et al. HIV seroprevalence among long-stay psychiatric patients. Hosp Commun Psychiatry. 1993;44:282–4.Google Scholar
  24. 24.
    Sacks MH, Dermatis H, Looser-Ott S, Perry S. Seroprevalence of HIV and risk factors for AIDS in psychiatric inpatients. Hosp Community Psychiatry. 1992;43:736–7.PubMedGoogle Scholar
  25. 25.
    Empfield M, Cournos F, Meyer I, McKinnon K, Horwath E, Silver M, et al. HIV seroprevalence among homeless patients admitted to a psychiatric inpatient unit. Am J Psychiatry. 1993;150:47–52.PubMedGoogle Scholar
  26. 26.
    Silberstein C, Galanter M, Marmor M, Lisshutz H, Krasinski K. HIV-1 among inner city dually diagnosed inpatients. Am J Drug Alcohol Abuse. 1994;20:101–31.PubMedCrossRefGoogle Scholar
  27. 27.
    Stewart DL, Zuckerman CJ, Ingle JM. HIV seroprevalence in a chronically mentally ill population. JAMA. 1994;86:519–23.Google Scholar
  28. 28.
    Susser E, Valencia E, Conover S. Prevalence of HIV infection among psychiatric patients in a New York City men’s shelter. AJPH. 1993;83:568–70.CrossRefGoogle Scholar
  29. 29.
    Volavka J, Convit A, Czobor P, Douyon R, O’Donnell J, Ventura E. HIV seroprevalence and risk behaviors in psychiatric inpatients. Psychiatry Res. 1991;39:109–14.PubMedCrossRefGoogle Scholar
  30. 30.
    Hanson M, Kramer TH, Gross W, Quintana J, Li PW, Asher R. AIDS awareness and risk behaviors among dually disordered adults. AIDS Educ Prev. 1992;4:41–51.PubMedGoogle Scholar
  31. 31.
    Kelly JA, Murphy DA, Bahr GR, Brasfield TL, Davis DR, Hauth AC, et al. AIDS/HIV risk behavior among the chronically mentally ill. Am J Psychiatry. 1992;149:886–9.PubMedGoogle Scholar
  32. 32.
    Knox MD, Boaz TL, Friedrich MA, Dow MG. HIV risk factors for persons with severe mental illness. Community Ment Health J. 1994;30:551–63.PubMedCrossRefGoogle Scholar
  33. 33.
    Steiner J, Lussier R, Rosenblatt W. Knowledge about and risk factors for AIDS in a day hospital population. Hosp Community Psychiatry. 1992;43:734–5.PubMedGoogle Scholar
  34. 34.
    Kalichman SC, Kelly JA, Johnson JR, Bulto M. Factors associated with risk for HIV infection among chronically mentally ill adults. Am J Psychiatry. 1994;151:221–7.PubMedGoogle Scholar
  35. 35.
    McKinnon K, Cournos F, Sugden R, Guido JR, Herman R. The relative contributions of psychiatric symptoms and AIDS knowledge to HIV risk behaviors among people with severe mental illness. J Clin Psychiatry. 1996;57:506–13.PubMedCrossRefGoogle Scholar
  36. 36.
    Katz RC, Watts C, Santman J. AIDS knowledge and high risk behaviors in the chronically mentally ill. Community Mental Health J. 1994;30:395–402.CrossRefGoogle Scholar
  37. 37.
    Gearon JS, Bellack AS. Women with schizophrenia and co-occurring substance use disorders: an increased risk for violent victimization and HIV. Community Ment Health J. 1999;35:401–19.PubMedCrossRefGoogle Scholar
  38. 38.
    Hatters-Friedman S, Loue S. Incidence and prevalence of intimate partner violence by and against women with severe mental illness. J Women’s Health. 2007;16:471–80.CrossRefGoogle Scholar
  39. 39.
    Weinhardt LS, Carey MP, Carey KB. HIV-risk behavior and the public health context of HIV/AIDS among women living with a severe and persistent mental illness. J Nerv Ment Dis. 1998;186:276–82.PubMedCrossRefGoogle Scholar
  40. 40.
    United Nations Department of Economic and Social Affairs. Population development and HIV/AIDS with particular emphasis on poverty: The concise report. New York: United Nations; 2005.Google Scholar
  41. 41.
    Cournos F, McKinnon K. HIV seroprevalence among people with severe mental illness in the United States: A critical review. Clin Psychology Rev. 1997;17:259–69.CrossRefGoogle Scholar
  42. 42.
    Brookings Institute. Cleveland in focus: a profile from census 2000. Washington, DC: Author; 2003. From URL: (2010). Retrieved 16 Aug 2010.
  43. 43.
    Ohio State University. The hispanic action plan. Columbus, OH: Author; 1991. From URL: (2010). Retrieved 16 August 2010.
  44. 44.
    United States Department of Housing and Urban Development. The state of the cities—1998: Part one: the state of America’s cities. Washington, DC: Author; 2005. From URL: (2010). Retrieved 16 Aug 2010.
  45. 45.
    United States Census Bureau. American factfinder: Fact sheet: Cuyahoga County, Ohio; 2008. From: URL: (2010). Retrieved 16 Aug 2010.
  46. 46.
    United States Census Bureau. State and county quickfacts: Cuyahoga County, Ohio; 2008. From: URL: Retrieved 16 Aug 2010.
  47. 47.
    Baker SS. Understanding mainland Puerto Rican poverty. Philadelphia, PA: Temple University Press; 2002.Google Scholar
  48. 48.
    Cleveland Department of Public Health. Cleveland only HIV/AIDS prevalence report, Reported persons living with HIV/AIDS as of December 31, 2007, final report. Cleveland, OH: Author; 2008.Google Scholar
  49. 49.
    Cleveland Department of Public Health. HIV/AIDS report for Cleveland, May 24. Cleveland, OH: Author; 2006.Google Scholar
  50. 50.
    Cleveland Department of Public Health. STD report for Cuyahoga County, 2004–2005. Cleveland, OH: Author; 2007.Google Scholar
  51. 51.
    Sajatovic M, Ramirez LF. Rating scales in mental health. Hudson, OH: Lexi-Comp Inc.; 2001.Google Scholar
  52. 52.
    McLellan AT, Luborsky L, Woody GE, O’Brien C. An improved diagnostic instrument for substance abuse patients. The addiction severity index. J Nerv Ment Dis. 1980;168(1):26–33.PubMedCrossRefGoogle Scholar
  53. 53.
    Marin G, Gamba RJ. A new measurement of acculturation for Hispanics: the Bidimensional Acculturation Scale for Hispanics (BAS). Hisp J Behav Sci. 1996;18:297–316.CrossRefGoogle Scholar
  54. 54.
    Miller JE, Guarnaccia PJ, Fasina A. AIDS knowledge among Latinos: the roles of language, culture, and socioeconomic status. J Immigrant Health. 2002;4:63–72.CrossRefGoogle Scholar
  55. 55.
    Loue S, Cooper M, Fiedler J. HIV knowledge among a sample of Puerto Rican and Mexican men and women. J Immigrant Health. 2003;5:59–66.CrossRefGoogle Scholar
  56. 56.
    Loue S, Cooper M, Fiedler J. HIV risk among a sample of Mexican and Puerto Rican men and women. J Health Care Poor Underserved. 2003;14:550–65.PubMedGoogle Scholar
  57. 57.
    Onwuegbuzie AJ, Teddlie C. A framework for analyzing data in mixed methods research. In: Tashakkori A, Teddlie C, editors. Handbook of mixed methods in social and behavioral research. Thousand Oaks, CA: Sage; 2003. p. 351–83.Google Scholar
  58. 58.
    Tashakkori A, Teddlie C. Mixed methodology: combining qualitative and quantitative approaches. Applied social research methods series, vol 46. Thousand Oaks, CA: Sage; 1998.Google Scholar
  59. 59.
    Hatters-Friedman S, Loue S, Heaphy ELG, Mendez N. Partner violence victimization and perpetration by Puerto Rican women with severe mental illnesses. Community Ment Health J. 2009; (e-pub ahead of print).Google Scholar
  60. 60.
    Cuffel BJ. Comorbid substance use disorder: prevalence, patterns of use, and course. New Directions Ment Health Serv. 1996;70:93–106.CrossRefGoogle Scholar
  61. 61.
    Regier DA, Framer ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the epidemiologic catchment area (ECA) Study. JAMA. 1990;264:2511–8.PubMedCrossRefGoogle Scholar
  62. 62.
    National Drug Intelligence Center. Drug abuse and mental illness: fast facts. Washington, DC.: United States Department of Justice; 2004.Google Scholar
  63. 63.
    Dixon L, Haas G, Weiden PJ, Sweeney J, Frances AJ. Drug abuse in schizophrenic patients: clinical correlates and reasons for use. Am J Psychiatry. 2001;148:224–30.Google Scholar
  64. 64.
    Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4:231–44.PubMedCrossRefGoogle Scholar
  65. 65.
    Knudsen P, Vilmar T. Cannabis and neuroleptic agents in schizophrenia. Acta Psychiatr Scand. 1984;69:162–74.PubMedCrossRefGoogle Scholar
  66. 66.
    Gandhi DH, Bogrov MU, Osher FC, Myers P. A comparison of the patterns of drug use among patients with and without severe mental illness. Am J Addictions. 2003;12:424–31.Google Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Department of Epidemiology and Biostatistics, Center for Minority Public HealthCase Western Reserve University School of MedicineClevelandUSA
  2. 2.Department of PsychiatryCase Western Reserve University School of MedicineClevelandUSA
  3. 3.Department of Epidemiology and BiostatisticsCase Western Reserve University School of MedicineClevelandUSA

Personalised recommendations